Stephanie Fountain, MD
Critical Care Medicine · Fargo, NDNPI 1528405917
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,000 of the $13,904 with a category attached, or 64.7%. Intuitive Surgical accounts for 74.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $10,418 and has fallen 89.5% since, to $1,095 in 2025.
Across 108 payments — averaging $128.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Olympus Corporation Of The Americas$1K
- Vantive US Healthcare LLC$1K
- GSK$375
- AstraZeneca$336
- Boehringer Ingelheim$280
- plus $369 from 15 others
What the payments were for
- Travel & lodging$3,14423%
- Food & beverage$1,76013%
- Education$9,00065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $10,305 |
| Olympus Corporation Of The Americas | 10 | $1,145 |
| Vantive US Healthcare LLC | 8 | $1,095 |
| GSK | 22 | $375 |
| AstraZeneca | 21 | $336 |
| Boehringer Ingelheim | 12 | $280 |
| Actelion Pharmaceuticals US, Inc. | 5 | $96 |
| La Jolla Pharmaceutical Company | 2 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Shire North American Group Inc | 1 | $24 |
| Mylan Specialty L.p. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $20 |
| Sanofi | 1 | $17 |
| Novartis | 1 | $17 |
| Veran Medical Technologies, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Electromed, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few critical care medicine providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $25,071 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $3,218 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,738 |
| Ipratropium Bromide | 18 | $965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $375 | $25,07119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few critical care medicine providers in North Dakotaon file to place this against a meaningful peer group, so we don't.
Other critical care medicine in Fargo
- Amber StolaFargo$11K
- Gwen ThompsonFargo$3K
- Mazen KherallahFargo$380
- Sohi AshrafFargo$122
- Arslan MahmoodFargo$66
- Nabil AbouchalaFargo$34
- Al ShanaFargo$20
- Anthony TelloBismarck$15K
- Kevin PriceMinot$274
- Joshua HoffmanBismarck$264
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.